Assessment of the peripheral benzodiazepine receptors in human gliomas by two methods

Journal of Neuro-Oncology

Volumn 38, Issue 1, 1998, Pages 19-26

  Miyazawa, Nobuhiko ^a   Hamel, Edith ^a   Diksic, Mirko ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Autoradiography; Liquid scintillation; Tumor differentiation

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RADIOLIGAND;

ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN CORTEX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIGAND BINDING; LIQUID SCINTILLATION COUNTING; RECEPTOR DENSITY; TUMOR DIFFERENTIATION;

EID: 0031930856     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005933226966     Document Type: Article

References (44)

1. 3H]PK-11195, an isoquinoline carboxamide derivative. Kinetic studies and autoradiographic lozalization. J Neurochem 41: 1744-1750, 1983
2. Gelhert DR, Yamamura HI, Wamsley JK: Autoradiographic localization of peripheral type benzodiazepine binding sites in the rat brain, heart and kidney. Naunyn Schmiedebergs Arch Pharmacol 328: 454-460, 1985
3. 3H]Ro5-4864 in rat brain and kidney. J Pharmacol Exp Ther 225: 461-469, 1983
4. Bender AS, Hertz L: Flunitrazepam binding to intact and homogenized astrocytes and neurons in primary culture. J Neurochem 43: 1319-1327, 1984
5. Ferrarese C, Appolino I, Frigo M, Gaini M, Piolit R, Frattola L: Benzodiazepine receptors and diazepam binding inhibitor in human cerebral tumors. Ann Neurol 26: 564-569, 1989
6. McCarthy K, Harden T: Identification of two benzodiazepine binding sites on cells cultured from rat cerebral cortex. J Pharmacol Exp Ther 216: 183-191, 1981
7. Syapin PJ, Skolnick P: Characterization of benzodiazepine binding sites in cultured cells of neural origin. J Neurochem 32: 1047-1051, 1979
8. Anholt RH, Pedersen PL, De Souza EB, Snyder SH: The peripheral-type benzodiazepine receptor: localization to the mitochrondrial outer membrane. J Biol Chem 261: 576-583, 1986
9. Junk L, Olson JM, Ciliax BJ, Koeppe R, Watkins G, Jewett D, McKeever P, Wieland D, Kilbourn M, Starosta-Rubinstein S, Mancini W, Kuhl D, Greenberg H, Young AB: PET imaging of human gliomas with ligands for peripheral benzodiazepine binding sites. Ann Neurol 26: 753-758, 1989
10. Snyder SH, McEnery MW, Verma A: Molecular mechanisms of peripheral benzodiazepine receptors. Neurochem Res 15: 119-123, 1990
11. Gavish M, Katz Y, Bar-Ami S, Weizman R: Biochemical, physiological and pathological aspects of the peripheral benzodiazepine receptors. J Neurochem 58: 1589-1601, 1992
12. Papadopoulos V: Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocrinology 14: 222-238, 1993
13. Alho H, Varga V, Krueger KE: Expression of mitochrondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth. Cell Growth Differ 5: 1005-1014, 1994
14. 3H-PK 14105]. J Pharmacol Exp Ther 249: 333-339, 1989
15. Benavides J, Fage D, Carter C, Scatton B: Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res 421: 167-172, 1987
16. 3H]flunitrazepam binding in kainatelesioned rat striatum and temporal cortex of brains from patients with senile dementia of the Alzheimer type. Brain Res 278: 373-375, 1983
17. 3H]Ro5-4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur J Pharmacol 71: 173-175, 1981
18. Zavala F, Lenfant M: Benzodiazepines and PK-11195 exert immunomodulating activities by binding to a specific receptor on macrophages. Ann N Y Acad Sci 496: 240-249, 1987
19. Ramsay SC, Weiller C, Myers R, Cremer JE, Luthra SK, Lammertsma AA, Frackowiak RSJ: Monitoring by PET of macrophage accumulation in brain after ischemic stroke. Lancet 339: 1054-1055, 1992
20. 3H]PK-11195 as a maker for gliosis. Acta Neurochir (Wien) 137: 207-216, 1995
21. 11C]PK11195 in vivo after induction of a cortical ischaemic lesion. Nucl Med Biol 19: 159-166, 1992
22. 3H]PK-11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab 11: 314-322, 1991
23. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barré L, Travère JM, Derlon JM, MacKenzie ET: In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke 24: 2046-2058, 1993
24. Johnson EW, deLanerolle NC, Kim JH, Sundaresan S, Spencer DD, Mattson RH, Zoghbi SS, Baldwin RM, Hoffer PB, Seibyl JP, Innes RB: 'Central' and 'peripheral' benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology 42: 811-815, 1992
25. 3H]-PK-11195 binding sites in human epileptic hippocampus. Epilepsia 33: 610-617, 1992
26. Starosta-Rubinstein S, Ciliax BJ, Penney JB, McKeever P, Young AB: Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc Natl Acad Sci 84: 891-895, 1987
27. Black KL, Ikezaki K, Toga AW: Imaging of brain tumors using peripheral benzodiazepine receptor ligands. J Neurosurg 71: 113-118, 1989
28. Takada A, Mitsuka S, Diksic M, Yamamoto YL: Autoradiographic study of peripheral benzodiazepine receptor in animal brain tumor models and human gliomas. Eur J Pharmacol, Environ Toxicol Pharmacol 228: 131-139, 1992
29. 3H]Diazepam binding in mammalian central nervous system: a pharmacological characterization. J Neurosci 1: 218, 1981
30. Ikezaki K, Black KL, Toga AW, Santori EM, Becker DP, Smith ML: Imaging peripheral benzodiazepine receptors in brain tumors in rats: in vitro binding characteristics. J Cereb Blood Flow Metab 10: 580-587, 1990
31. Van Dort ME, Ciliax BJ, Gildersleeve DL, Sherman PS, Rosenspire KC, Young AB, Junck L, Wieland DM: Radioiodinated benzodiazepine: agents for mapping glial tumors. J Med Chem 31: 2081-2086, 1988
32. Pappata S, Cornu P, Samson Y, Prenant C, Benavides J, Scatton B, Crouzel C, Hauw JJ, Syrota A: PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J Nucl Med 32: 1608-1610, 1991
33. Black KL, Ikezaki K, Santory E, Becker DP, Vinters HV: Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rats and man. Cancer 65: 93-97, 1990
34. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
35. Cornu P, Benavides J, Scatton B, Hauw JJ, Philippon J: Increase in ω3 (peripheral-type benzodiazepine) binding site densities in different type of human brain tumor: a quantitative autoradiography study. Acta Neurochir (Wien) 119: 146-152, 1992
36. Miettinen H, Kononen J, Haapasalo H, Helène P, Sallinen P, Harjuntausta T, Helin H, Alho H: Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res 55: 2691-2695, 1995
37. Takeda N, Diksic M, Yamamoto YL: The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and pheripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy. Cancer 77: 1167-1179, 1996
38. 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. Ann Nucl Med 3: 63-71, 1989
39. Jewett DM, Magner TJ, Watkins GL: Captive solvent methods for fast, simple carbon-11 radioalkylations. In: Emran AM (ed.) New Trends in Radiopharmaceutical Synthesis, Quality Assurance and Regulatory Control. Plenum Press, N.Y., 1991
40. 11C]PK 11195 to ω3 sites in baboons: positron emission tomographic study. Eur J Pharmacol 200: 347-351, 1991
41. 125I]-labelled analog of PK 11195, potential agent for SPECT imaging of the peripheral benzodiazepine binding site. Nucl Med Biol 16: 423-429, 1989
42. Ferarrese C, Pierpaoli C, Linfante I, Bobo RH, Guthrie B, Kufta C, Duhaney MO, Melisi J, Fulham MJ: Peripheral benzodiazepine receptors and glucose metabolism in human glioma. J Neuro-Oncol 22: 15-22, 1994
43. Ernestus RI, Wilmes LJ, Hoehn-Berlage M: Identification of intracranial liquor metastases of experimental stereotactically implanted brain tumors by the tumor-selective MRI contrast agent Mn-TPPS. Clin Exp Metastasis 10: 345-350, 1992
44. Ikezaki K, Nomura T, Takahasi M, Fritz-Zieroth B, Inamura T, Fukui M: Selective and prolonged MRI enhancement by Mn-TPPS in an experimental rat brain tumor with peripheral benzodiazepine receptors. Neurol Res 16: 393-397, 1994